LITS Stock Forecast: Lite Strategy, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$0.80
−4.45% on the day

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 33 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$23.9M
Ticker Nerd rank
33/ 100
Median analyst target
—
Analysts covering
—
Revenue$0.0
Operating income−$2.8M
Net income−$23.7M
Free cash flow−$1.5M
Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.6%
1M
−32.6%
YTD
−39.2%
1Y
−52.8%
From 52W high
−58.2%
From 52W low
+8.5%
$0.74
$1.92
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Lite Strategy, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
33/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
95
Issuance
61
Volatility
55
Value
43
Momentum
39
Revisions
20
Growth
12
Quality
10

Accruals (95): Reported profit is backed by cash, and the company is not expanding recklessly.

Quality (10): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

LITS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on LITS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.60$0.80$1.00$1.20$1.40$1.60$1.80$2.00Jan 26Apr 26Jul 26Oct 26LITS

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

LITS appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

LITS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Lite Strategy, Inc. returned −52.8% against +6.9% for the S&P 500, dividends included.

LITS vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26LITSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

LITS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
—
Price / book
0.4×

Cheaper than 88% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−60.9%

Higher than 19% of US stocks

Return on assets
−8.3%

Higher than 28% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Lite Strategy, Inc. has a market value of $23.9M and an enterprise value of $19.7M.

  • Revenue in the twelve months to 31 Mar 2026: $0.0.

  • Net income over the same four quarters: −$60.8M.

  • Free cash flow in the twelve months to 31 Mar 2026: −$10.4M, after $0.0 of capital spending.

  • Shares outstanding: 35.2M.

  • Lite Strategy, Inc. employs 5 people.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 22 Nov 2026

Data provided by Twelve Data

Peers

LITS and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
LITSLite Strategy, Inc.$23.9M33
PTHSPelthos Therapeutics, Inc.$24.4M37
INMBINmune Bio, Inc.$25.6M38
ABVCABVC BioPharma, Inc.$23.1M20
LONALeonaBio, Inc.$26.4M25
EYPTEyePoint, Inc.$26.6M21
TELOTelomir Pharmaceuticals, Inc.$26.8M27

Take a look at LITS’s peer groups, ranked by the model: financial stocks · biotech stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Lite Strategy, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about LITS

How does Ticker Nerd's model rank LITS?

As at 21 Nov 2026, Lite Strategy, Inc. ranks 33 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (95 of 100).

What is the LITS stock forecast for 2030?

No analyst covering Lite Strategy, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LITS are extrapolating price history, which says nothing about the business.

How has LITS stock performed over the past year?

Lite Strategy, Inc. returned -52.8% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Lite Strategy, Inc. do?

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset.

Company

About Lite Strategy, Inc.

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

CEO Mr. Justin J. File CPA · 5 employees · United States · https://www.litestrategy.com